Calcium and phosphate metabolism Flashcards

1
Q

What is osteoporosis and its causes

A

Loss of bone mass (mineral and organic matrix)

Causes:

  • endocrine
  • malignancy
  • drug induced
  • renal disease
  • nutritional
  • age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is osteoporosis diagnosed?

A

Measurement of bone mineral density (BMD)

Measurement made by dual energy X-ray absorptiometry (DEXA or DXA) scan, uses two x-ray machine, compare results

In healthy person bone density peaks at 25-35

0 SD mean you have the same bone mass as a young adult based on population averages. Expected rate with age drops

T score

  • Number of SDs below average for young adult at peak bone density

Z score

  • Matched to age and/or group

Normal T score: of –1 or above

Osteopenia: T-score lower than –1 and greater than –2.5

Osteoporosis: T-score of –2.5 or lower

Severe Osteoporosis: T-score of –2.5 or lower and presence of at least one fragility fracture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the endocrine causes of osteoporosis?

A

Hypogonadism – cause of oestrogen deficiency - in males or females. More common in females that are post-menopausal because oestrogen levels drop and incidence of osteoporosis increases

Excess glucocorticoids – endogenous or exogenous e.g due to Cushing’s which if untreated can cause osteoporosis or glucocorticoid therapy maintained for too long

Hyperparathyroidism – elevated levels of parathyroid hormone leads to excess resorption over bone formation

Hyperthyroidism – increases bone metabolism and can also if untreated be a risk factor for osteoporosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors for accelerating the rate of bone loss?

A
  1. A los peak in the peak bone mass during growth and development, don’t achieve healthy average. Bone loss continues, starting from lower peak.
  2. Early menopause, before 45, results in increased rate of bone loss, possibly leading onto osteoporosis
  3. Following normal menopause some women lose bone mass at faster rate than others - greater risk of osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the treatments for osteoporosis?

A

Ensure adequate calcium and vitamin D intake

Postmenopausal HRT

Bisphosphonates - risedronate, alendronate

PTH analogues

Denosumab - human monoclonal antibody against Rank Ligand

Romosozumab - human monoclonal antibody against sclerostin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does bisphosphonates treat osteoporosis?

A

Inhibits function of osteoclasts

Reduces rate of bone turnover / osteoclast involement in bone resportion

issue - bone remodelling is supposed to happen, so concerns about prolonged use could still lead to boen changes due to lack of remodelling

first line of treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do PTH analogues treat osteoporosis?

A

PTH usually icnreases bone remodelling, but depends on levels

Moderate levels promote bone remodelling, increase in bone resorption and formation

Prolonged high PTH leads to increased resorption, resorption part predominates over formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does romosozuman treat osteoporosis?

A

A human monoclonal antibody against sclerostin, protien which puts break on WNT signalling, therefore stops osteoblast differentiation.

Antagonising this proteins redcues available levels of protein, takes break off

promotes bone formation

anabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is osteomalacia?

A

Loss of bone mineralisation (rickets in children) - makes bones soft and malleable

Less common than osteoporosis - which is loss of bone mineralisation and bone matrix.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the signs and symptoms of osteomalacia?

A

Permanent deformities in bone growth (rickets) if left untreated

Diffuse aches and pains

Weak bones , difficulty in walking in adults

Low plasma Ca, Pi

Elevated alkaline phosphatase, an enzyme that is a marker of bone turnover.

PTH may be elevated, secondary to low calcium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the causes of osteomalacia?

A

Vitamin D deficiency (most common), lack of sunlight and supplementation is common cause in kids, also in elderly adults that don’t go out as much

Mutations leading to errors in vitamin D metabolism (Rare)

Hypophosphatemia

Treatment most commonly involves ensuring adequate vitamin D and Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is hypocalcaemia a hallmark of conditions involing vitamin D deficiency?

A

Because vitamin D promotes calcium and phosphate absorption from the gut.

In lab results of osteomalacia you would expect:

  • Hypocalcaemia
  • With some degree of hypophosphataemia
  • Mediate precursor of 1,25(OH)2D3 low so vit D low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where is the main circulating precursor of vitamin D3 catalysed?

What increases and decreases the reaction?

A

25 OH D3 catalysed in kidneys by alpha hydroxylase enzyme, product is active form. - Calcitriol 1,25(Oh)2D3

Reaction is increased by

  • PTH
  • Low plasma Ca
  • Low plasma Pi

Decreased by / downregulated by

  • FGF-23 from osteocytes
  • High plasma Ca
  • High plasma pi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is there high PTH in osteomalacia and hypocalcaemia?

A

Secondary hyperparathyroidism due to the low calcium.

Vitamin D deficiency elevated PTH, secondary to the low calcium because the low calcium is what stimulates PTH production, which is how PTH is controlled in negative feedback loop with plasma Ca conc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two rare mutations that cause vitamin D dependent rickets?

A

Type 1 - 1 alpha hydroxylase mutation

1a hydroxylase mutation imapcts calcitriol production, active form is not being made/at low levels

  • low calcium and phosphate
  • high PTH levels in response to high calcium

Type 2- vitamin D receptor mutation , makes it less sensitive to vitamin D binding

  • Vit D precursor levels normal
  • Calcitriol high - low ca and pi stimulates calcitriol production as a normal response
  • calcitriol ineffective due to receptor mutation
  • PTH high - secondary hyperparathyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the effect of FGF-23?

A

Inhibits conversion of vitamin d (precursor) into calcitriol

increases phosphate excretion

FGF-23 secreted in response to rising phosphate, effect is to decrease phosphate - in a negative feedback loop with phosphate

Calcitriol increases phosphate absorption from the gut, hence FGF-23 also inhivits conversion into calcitriol

17
Q

What are three examples of rare conditions that lead to low calcium, phosphate and osteomalacia?

A

X-linked hypophosphatemia rickets

Autosomal domiannt hypophosphatemia rickets

  • both genetic, caused by single gene mutations

Oncogenic osteomalacia via benign tumour

in common:

  • FGF-23 is elevated, high in all of them
  • Leading to low phosphate
  • Excess FGF-23 either due to a mutation or in oncogenic osteomalacia it is ectopic FGF-23 secretion through a benign tumour.
  • calcium and calcitriol can be normal or low
  • FGF-23 is inhibiting calcitriol but low phosphate os stimulating factor for calcitriol,hence may be normal levels
  • low calcium promotes PTH producion -but calcitriol may not be signicantly reduced and PTH may be normal
18
Q

What mutation increases FGF-23 concentration?

A

In peptide between 169-179 there is recognition sequence, site for proteolytic cleavage, limits half-life of FGF-23 in circulation

mutation in recognition sequence, leaving intact, active peptide in circulation for longer - causes rise in FGF023 concentration

19
Q

What are the levels of calcium and phosphate in bone disease and renal failure?

A

Low calcium

Low Pi

Nomral precursor 25 OH D3

low calcitriol

high PTH

20
Q

What is renal osteodystrophy?

A

Disorders associated with renal failure where there is calcium and phosphate disturbances associated with bone damage

Develop a condition with falling plasma calcium and rising plasma phosphate:

  • High phosphate will be detected by osteocytes, they increase secretion of FGF-23
  • FGF-23 will normally increase phosphate excretion but this is impaired, so it only increases inhibition of calcitriol.
  • Impaired renal function associated with impaired H+ excretion, H+ conc in plasma increases, pH decreases, there is acidosis.
  • Acidosis favours bone demineralisation, adding onto collection of effects.
21
Q
A